Phathom Pharmaceuticals
$11.14
26
+$0.03+0.27% Wednesday 19:59
Statistics
Day High
11.83
Day Low
11.04
52W High
18.31
52W Low
2.21
Volume
934,148
Avg. Volume
1,170,255
Mkt Cap
792.48M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12MayExpected
Expected EPS
-0.2687
Actual EPS
N/A
Financials
-605.09%Profit Margin
Unprofitable110.5MRevenue
-668.65MNet Income
Analyst Ratings
$23.00Average Price Target
The highest estimate is 26.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PHAT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Takeda Pharmaceutical
TAK
Mkt Cap42.62B
Astrazeneca
AZN
Mkt Cap256.58B
Abbvie
ABBV
Mkt Cap385.18B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Sanofi
SNY
Mkt Cap124.45B
Pfizer
PFE
Mkt Cap140.15B
Novartis
NVS
Mkt Cap237.61B
Merck
MRK
Mkt Cap214.76B
GSK
GSK
Mkt Cap94.51B
About
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Show more...
CEO
Mr. David A. Socks
Employees
427
Country
US
ISIN
US71722W1071
Listings
0 Comments
Share your thoughts
FAQ
What is Phathom Pharmaceuticals stock price today?▼
The current price of PHAT is $11.14 USD — it has increased by +0.27% in the past 24 hours. Watch Phathom Pharmaceuticals stock price performance more closely on the chart.
What is Phathom Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Phathom Pharmaceuticals stocks are traded under the ticker PHAT.
Is Phathom Pharmaceuticals stock price growing?▼
PHAT stock has risen by +3.24% compared to the previous week, the month change is a -2.79% fall, over the last year Phathom Pharmaceuticals has showed a +102.91% increase.
What is Phathom Pharmaceuticals market cap?▼
Today Phathom Pharmaceuticals has the market capitalization of 792.48M
When is the next Phathom Pharmaceuticals earnings date?▼
Phathom Pharmaceuticals is going to release the next earnings report on May 12, 2026.
What were Phathom Pharmaceuticals earnings last quarter?▼
PHAT earnings for the last quarter are -0.29 USD per share, whereas the estimation was -0.41 USD resulting in a +29.61% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Phathom Pharmaceuticals revenue for the last year?▼
Phathom Pharmaceuticals revenue for the last year amounts to 110.5M USD.
What is Phathom Pharmaceuticals net income for the last year?▼
PHAT net income for the last year is -668.65M USD.
How many employees does Phathom Pharmaceuticals have?▼
As of April 02, 2026, the company has 427 employees.
In which sector is Phathom Pharmaceuticals located?▼
Phathom Pharmaceuticals operates in the Health Care sector.
When did Phathom Pharmaceuticals complete a stock split?▼
Phathom Pharmaceuticals has not had any recent stock splits.
Where is Phathom Pharmaceuticals headquartered?▼
Phathom Pharmaceuticals is headquartered in Florham Park, US.